US5320616A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement
Assignee: Alza Corp
•
Filing: 1991-11-07
•
Granted: 1994-06-14
•
Expires: 2011-11-07
Abstract
Abstract A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the passage of fluid into the system and a composition that permits the passage of fluid into the system. The lumen comprises a beneficial agent and an expandable member. The delivery system comprises an exit means for delivering the beneficial agent.
Inventors
- 👤 Judy A. Magruder
- 👤 James B. Eckenhoff
- 👤 Richard Cortese
- 👤 Jeremy C. Wright
- 👤 John R. Peery
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 20:49
CPC Classifications
A; A61; A61M; A61M31/00; A61K; A61K9/00; A61K9/0002; A61K9/0004; A61M31/002
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
235 words
A delivery system for delivering a beneficial agent to a fluid environment of use, wherein the delivery system comprises: (a) two wall sections, said sections comprising: (b) a first wall section comprising a polymer composition that substantially limits the passage of zero to one ml per day of fluid through the first wall section; (c) a second wall section comprising a cellulosic polymer composition pervious to the passage of fluid, which first wall section and second wall section surround; (d) a reservoir formed by the two sections assembled together by at least one process selected from fusion, adhesion and telescopic engagement; (e) 5 nanograms to 40 grams of a fluid sensitive biological beneficial agent in the reservoir and surrounded by the first wall section for protecting the beneficial agent from the fluid; (f) 0.1% to 90% of a pharmaceutically acceptable carrier in the reservoir surrounded by the first wall section and blended with the beneficial agent for transporting the beneficial agent from the reservoir; (g) a composition comprising a fluid absorbing hydrophilic polymer for expanding and pushing the beneficial agent from the first wall section of the reservoir, said composition in the reservoir surrounded by the second wall section pervious to the passage of fluid; and (h) an exit in the first wall section connecting the beneficial agent with the environment of use for delivering the beneficial agent at a hydrodynamically controlled rate over time.
Claim 2
Dependent Claim
235 words
A delivery system for delivering a beneficial agent to a fluid environment of use, wherein the delivery system comprises: (a) two wall sections, said sections comprising: (b) a first wall section comprising a polymer composition that substantially limits the passage of zero to one ml per day of fluid through the first wall section; (c) a second wall section comprising a cellulosic polymer composition pervious to the passage of fluid, which first wall section and second wall section surround; (d) a reservoir formed by the two sections assembled together by at least one process selected from fusion, adhesion and telescopic engagement; (e) 5 nanograms to 40 grams of a fluid sensitive biological beneficial agent in the reservoir and surrounded by the first wall section for protecting the beneficial agent from the fluid; (f) 0.1% to 90% of a pharmaceutically acceptable carrier in the reservoir surrounded by the first wall section and blended with the beneficial agent for transporting the beneficial agent from the reservoir; (g) a composition comprising a fluid absorbing hydrophilic polymer for expanding and pushing the beneficial agent from the first wall section of the reservoir, said composition in the reservoir surrounded by the second wall section pervious to the passage of fluid; and (h) an exit in the first wall section connecting the beneficial agent with the environment of use for delivering the beneficial agent at a hydrodynamically controlled rate over time.
Claim 3
Dependent Claim
61 words
The delivery system for delivering the beneficial agent according to claim 1, wherein the beneficial agent is a member selected from the group consisting of a pharmacologically active peptide, protein, anabolic hormone, growth promoting hormone, endocrine hormone, porcine growth promoting hormone, bovine growth promoting hormone, equine growth promoting hormone, human growth promoting hormone, and growth promoting hormone produced by recombinant DNA.
Claim 4
Dependent Claim
19 words
The delivery system for delivering the beneficial agent according to claim 1, wherein the delivery system is an implant.
References Cited (Backward Citations)
US2779241A
Cited
US3854480A
Cited
US3896819A
Cited
US3845761A
Cited
US3865108A
Cited
US3845770A
Cited
US3916899A
Cited
US3995632A
Cited
US4179337A
Cited
US3882233A
Cited
US4002173A
Cited
US4088864A
Cited
US4077407A
Cited
US4160020A
Cited
US4063064A
Cited
US4111202A
Cited
US4111203A
Cited
US4203439A
Cited
US4207893A
Cited
US4285987A
Cited
US4200098A
Cited
US4235236A
Cited
US4309996A
Cited
US4320759A
Cited
US4350271A
Cited
US4327725A
Cited
US4526938A
Cited
US4612008A
Cited
US4652630A
Cited
US4652630B1
Cited
US4599229A
Cited
US4765980A
Cited
US4855141A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-06-13 | 1997-12-13 | 1998-06-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-06-13 | 2001-12-13 | 2002-06-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-06-13 | 2005-12-13 | 2006-06-14 | $7700.00 | Window Closed / Lapsed |